Basal activities and hormone responsiveness of osteoclast-like and osteoblast-like bone cells are regulated by glucocorticoids.
Isolated bone cells demonstrate cell-type specific responses to glucocorticoids. Osteoclast-like (OC) cells exhibit a large decrease in basal hyaluronate synthesis at physiological doses of glucocorticoids and resistance to further inhibition by pharmacological doses up to 10(-4) M. This effect is not accompanied by decreases in protein synthesis. In contrast, osteoblast-like (OB) cell metabolism is not inhibited by physiological doses of glucocorticoids. However, in OB cells both citrate decarboxylation and collagen synthesis are decreased at pharmacological doses of glucocorticoids and these effects are accompanied by a decrease in general protein synthesis. In addition to these effects on basal and general cell activities, physiological doses of glucocorticoids modulate the hormonal sensitivity of OC and OB bone cells such that lower concentrations of bovine parathyroid hormone (PTH) are necessary to elicit measurable biochemical changes. As a result, the presence of glucocorticoids permits significant responses to PTH to be detected at doses as low as 2 x 10(-13) M in OC and OB bone cells.
D000818:Animals; D002478:Cells, Cultured; D002951:Citrates / Q000378:metabolism; D003907:Dexamethasone / Q000494:pharmacology*; D005944:Glucosamine / Q000378:metabolism; D006820:Hyaluronic Acid / Q000096:biosynthesis; D007700:Kinetics; D007930:Leucine / Q000378:metabolism; D051379:Mice; D010006:Osteoblasts / Q000187:drug effects / Q000378:metabolism*; D010010:Osteoclasts / Q000187:drug effects / Q000378:metabolism*; D010281:Parathyroid Hormone / Q000494:pharmacology*; D011239:Prednisolone / Q000494:pharmacology*; D014176:Protein Biosynthesis
D002951:Citrates; D010281:Parathyroid Hormone; D003907:Dexamethasone; D006820:Hyaluronic Acid; D011239:Prednisolone; D007930:Leucine; D005944:Glucosamine